MedTrace Logo

Sub-Sensitivity to Long-Acting Bronchodilators (LABA)

NCT01117116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-01-19

No results posted yet for this study

Summary

The purpose of this study is to look at whether Advair® and SYMBICORT® have different effects on airway constriction by means of methacholine challenge testing.

Conditions

Interventions

DRUG

fluticasone propionate and salmeterol

45/4.5 two puffs twice daily

DRUG

budesonide and formoterol

80/4.5 two puffs twice daily

Sponsors & Collaborators

  • National Jewish Health

    lead OTHER

Principal Investigators

  • Rohit K Katial, M.D. · National Jewish Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01117116 on ClinicalTrials.gov